Your browser doesn't support javascript.
loading
Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint.
Wu, Zhen-Hua; Li, Na; Mei, Xiao-Feng; Chen, Juan; Wang, Xiao-Ze; Guo, Ting-Ting; Chen, Gang; Nie, Lei; Chen, Yao; Jiang, Mei-Zhu; Wang, Ji-Teng; Wang, Hai-Bin.
Affiliation
  • Wu ZH; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Li N; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Mei XF; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Chen J; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Wang XZ; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Guo TT; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Chen G; BioRay Pharmaceutical Corp, San Diego, California, USA.
  • Nie L; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Chen Y; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Jiang MZ; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Wang JT; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China.
  • Wang HB; BioRay Pharmaceutical Co., Ltd, Taizhou, Zhejiang, China haibin.wang@bioraypharm.com.
J Immunother Cancer ; 10(3)2022 03.
Article in En | MEDLINE | ID: mdl-35256517

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD47 Antigen / Neoplasms Limits: Animals / Humans Language: En Journal: J Immunother Cancer Year: 2022 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD47 Antigen / Neoplasms Limits: Animals / Humans Language: En Journal: J Immunother Cancer Year: 2022 Type: Article Affiliation country: China